Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Certa Therapeutics Logo
Certa Therapeutics Growth Score
3
CB Rank
77803
Heat Score
45
Certa Therapeutics is a clinical stage biotechnology company developing innovative therapies for the treatment of fibrotic diseases.
Founded
obfuscation
PrivateGrant Melbourne, Victoria, Australia11-50 certatherapeutics.com/
Biotechnology
Manufacturing
Therapeutics
Overview

Certa Therapeutics
Total Funding
obfuscation
Growth Score
3
Heat Score
45

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score3
-34 pts
in past quarter
Heat Score 45
0 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Certa Therapeutics

CB Rank
77803
Certa Therapeutics is a clinical stage biotechnology company developing innovative therapies for the treatment of fibrotic diseases.
Founded
obfuscation
PrivateGrant Melbourne, Victoria, Australia11-50 certatherapeutics.com/
Biotechnology
Manufacturing
Therapeutics

Funding Rounds

Grant
OBF
in
obfuscation

Key People

Details

Legal Name Certa Therapeutics Pty Ltd
Operating Status Active
Company Type For Profit
Founders  Darren Kelly
Contact Email info@certatherapeutics.com
Predictions & Insights

Growth Insight

See this Growth Insight
Certa Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Merger or Acquisition

Products & Services

Asengeprast (FT011)
An oral small molecule inhibitor targeting GPR68 for treating systemic sclerosis and other fibrotic diseases by modulating fibrosis pathways.
OCX063
An oral small molecule GPR68 inhibitor in development for focal segmental glomerulosclerosis, targeting kidney fibrosis.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Certa Therapeutics Logo
Grant - Certa Therapeutics
4
obfuscation
Brandon CapitalGrant
obfuscation
Grant - Certa Therapeutics Logo
Grant - Certa Therapeutics
4
obfuscation
Brandon CapitalGrant
obfuscation
Grant - Certa Therapeutics Logo
Grant - Certa Therapeutics
4
obfuscation
Brandon CapitalGrant
obfuscation
Grant - Certa Therapeutics Logo
Grant - Certa Therapeutics
4
obfuscation
Brandon CapitalGrant
obfuscation
Grant - Certa Therapeutics Logo
Grant - Certa Therapeutics
4
obfuscation
Brandon CapitalGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Certa Therapeutics Logo
Grant - Certa Therapeutics
4
obfuscation
Brandon CapitalGrant
obfuscation
Grant - Certa Therapeutics Logo
Grant - Certa Therapeutics
4
obfuscation
Brandon CapitalGrant
obfuscation
Grant - Certa Therapeutics Logo
Grant - Certa Therapeutics
4
obfuscation
Brandon CapitalGrant
obfuscation
Grant - Certa Therapeutics Logo
Grant - Certa Therapeutics
4
obfuscation
Brandon CapitalGrant
obfuscation
Grant - Certa Therapeutics Logo
Grant - Certa Therapeutics
4
obfuscation
Brandon CapitalGrant

Investors

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1 Contacts 3

Employee Profiles

News

News and Press

News•Oct 1, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 1, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 27, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 26, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

666
1,413.64%
 in past month

Active Website Tech Count

27Certa Therapeutics is actively using 27 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, SSL by Default, and  Viewport Meta.

Total IP

15The intellectual property of Certa Therapeutics includes 15 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Certa Therapeutics's headquarters? Certa Therapeutics is located in Melbourne, Victoria, Australia.Who invested in Certa Therapeutics? Certa Therapeutics has 4 investors including MRCF Biomedical Translation Fund and  Brandon Capital.When was the last funding round for Certa Therapeutics? Certa Therapeutics closed its last funding round on
obfuscation
from a Grant round.Who are Certa Therapeutics's competitors? Alternatives and possible competitors to Certa Therapeutics may include Novartis, AstraZeneca, and  Bristol-Myers Squibb.How much funding has Certa Therapeutics raised to date? Certa Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(85d1f87 1)
|